Graham Capital Management’s ResMed RMD Stock Holding History

Graham Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Sell	13,880 -3,392	-20%	-$703K	0.05%	271
2026 Q1	$3.88M	Sell	17,272 -4,205	-20%	-$1.05M	0.09%	160
2025 Q4	$5.17M	Buy	21,477 +13,801	+180%	+$3.53M	0.12%	109
2025 Q3	$2.1M	Sell	7,676 -9,315	-55%	-$2.54M	0.03%	221
2025 Q2	$4.38M	Buy	+16,991	New	+$4.05M	0.07%	165
2025 Q1	–	Sell	-1,240	Closed	-$284K	–	1483
2024 Q4	$284K	Sell	1,240 -3,939	-76%	-$948K	﹤0.01%	956
2024 Q3	$1.26M	Buy	5,179 +1,805	+53%	+$403K	0.02%	395
2024 Q2	$646K	Buy	+3,374	New	+$685K	0.01%	504
2023 Q3	–	Sell	-25,668	Closed	-$5.61M	–	1251
2023 Q2	$5.61M	Buy	25,668 +819	+3%	+$183K	0.16%	98
2023 Q1	$5.44M	Buy	24,849 +7,441	+43%	+$1.61M	0.17%	80
2022 Q4	$3.62M	Buy	17,408 +13,445	+339%	+$2.95M	0.11%	106
2022 Q3	$865K	Buy	+3,963	New	+$902K	0.03%	545

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Graham Capital Management's RMD Position: Q2 2026 in Review

Graham Capital Management reduced its ResMed (RMD) stake by 20% in Q2 2026, selling an estimated $703K and leaving 13,880 shares worth $2.7M. The position accounts for 0.05% of the portfolio, ranked #271.

Graham Capital Management first reported a position in RMD in Q3 2022 and has held it in 12 quarters since. The position peaked at $5.61M in Q2 2023. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Graham Capital Management held 13,880 shares of ResMed worth $2.7M as of Q2 2026.
Graham Capital Management sold 3,392 ResMed shares in Q2 2026, an estimated $703K.
ResMed made up 0.05% of Graham Capital Management's portfolio in Q2 2026, its #271 holding.
Graham Capital Management first reported a position in ResMed in Q3 2022 and has held it in 12 quarters since.
Graham Capital Management's ResMed position peaked at $5.61M in Q2 2023.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.